EcoDrugPlus

Integrin Subunit Alpha 5

Ensembl ID : ENSLBEG00000010065
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSLBEG00000001395
Gene Symbol: ITGB1
4 Cross references
227 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSLBEG00000001352
Gene Symbol: ITGB1
2 Cross references
227 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSLBEG00000023090
Gene Symbol: ITGB5
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSLBEG00000025999
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSLBEG00000024512
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSLBEG00000004775
Gene Symbol: IRAK4
3 Cross references
201 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4-Like

Ensembl ID : ENSLBEG00000013356
Gene Symbol: LOC109993089
3 Cross references
201 Possible Orthologues:

Interleukin-6-Like

Ensembl ID : ENSLBEG00000024724
Gene Symbol: LOC109982488
2 Cross references
162 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSLBEG00000002970
Gene Symbol: LOC109989974
3 Cross references
183 Possible Orthologues:

Intermediate Conductance Calcium-Activated Potassium Channel Protein 4-Like

Ensembl ID : ENSLBEG00000011010
Gene Symbol: LOC109986636
2 Cross references
187 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSLBEG00000027160
Gene Symbol: LOC110002801
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).